EOMBA PUNGU: Open Payments
NPI 1174047070 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 29 payments from 6 companies in 2025. Trend: 2023 $686 · 2024 $757 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $272 |
| Amgen Inc. | 12 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Lilly USA, LLC | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Wegovy, KRYSTEXXA, REPATHA, Kerendia, FARXIGA, ZEPBOUND, MOUNJARO, Ozempic.
Industry payments across NC — which companies pay providers there.
